-
Despite federal efforts, drug prices may not drop much
Three years after Congress passed the Inflation Reduction Act in 2022, a significant change from that law will go into effect next month. The law gives the federal Centers for Medicare and Medicaid Services (CMS) the right to negotiate the prices of high-cost prescription drugs and forces drug companies to give back money when they…
-
Tariffs and meds: What health journalists should watch for now
The story of tariffs on prescription medications has shifted quickly in recent weeks, with new trade agreements, industry reactions, and policy twists reshaping what patients may experience at the pharmacy counter. One notable shift came with a new U.S.–EU trade agreement: branded drugs from Europe will now face a modest 15% tariff cap, while generics and…
Got any book recommendations?